Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ROIC - WACC | 10.7% | 8.1% | 10.2% | 7.3% | 14.4% | 7.3% | 3.5% | 5.1% | 6.9% | 5.3% | 5.5% | 5.6% | 5.5% | 10.7% | 6.7% | 7.7% | 5.4% | 17.8% | 25.8% | (2.2%) |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, Microsoft Corp's last 12-month ROIC - WACC is 1.0%, based on the financial report for Sep 29, 2024 (Q3 2024). The average annual ROIC - WACC for Pfizer Inc. have been 9.9% over the past three years, and 9.3% over the past five years.
As of today, Pfizer Inc.'s ROIC - WACC is 1.0%, which is lower than industry median of 8.9%. It indicates that Pfizer Inc.'s ROIC - WACC is Bad.